HLB Life Science

067630 · KOSDAQ · Health Care · SMALL CAP

Early redemption of convertible bonds (incl. overseas CBs)

HLB Life Science Co., Ltd. acquired US$439K face value of its Series 13 convertible bonds (issued August 29, 2024, maturing August 29, 2027, conversion price US$5.86 per share after adjustment) on August 31, 2026 following the bondholder's exercise of its early redemption request (put option), paying US$449K including principal and interest, leaving US$439K face value outstanding; the bonds will be deregistered with the Korea Securities Depository.

Capital raise(Early redemption of convertible bonds (incl. overseas CBs))· FILED 2026-08-31· RCEPT 20260831900610

What happened

HLB Life Science / Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity / (2026.08.31) Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13)

Convertible Bonds (Incl. Overseas CBs) - Series 13

1. Matters concerning the bonds acquired prior to maturity Type of bond: Unregistered, unsecured, privately placed convertible bonds Issue date: 2024-08-29 Issuance method: Domestic issuance (private placement) Conversion price per share (KRW): 8,008 Maturity date: 2027-08-29

2. Bond acquisition amount (currency unit): 613,711,800 KRW: South Korean Won - Face value (electronically registered amount) of the bonds acquired (currency unit): 600,000,000 KRW: South Korean Won - Applicable exchange rate: - - Acquisition date: 2026-08-31

3. Face value (electronically registered amount) of the bonds remaining after acquisition (currency unit): 600,000,000 KRW: South Korean Won

4. Reason for acquisition prior to maturity and future handling method - Reason for acquisition: Exercise of the bondholder's early redemption request right (put option) - Future handling method: Deregistration of the registered bonds with the Korea Securities Depository

5. Source of acquisition funds: Own funds

6. Method of acquiring the bonds: Over-the-counter purchase

7. Other matters for reference in investment decisions - The "conversion price per share" in "1. Matters concerning the bonds acquired prior to maturity" above is the final price as adjusted on May 29, 2025. - The "2. Bond acquisition amount" above includes the principal and interest of these bonds. - The "3. Face value (electronically registered amount) of the bonds remaining after acquisition" above is the total face value of unconverted convertible bonds held by the bondholder after excluding this acquisition. - The above "acquisition date" is the date the bond acquisition amount was paid. * Related disclosures: 2024-08-21 Decision to Issue Convertible Bonds (Series 13) 2024-11-29 Adjustment of Conversion Price 2025-02-28 Adjustment of Conversion Price 2025-05-29 Adjustment of Conversion Price (Series 13) 2026-02-19 Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13) 2026-02-25 Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13) 2026-03-03 Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13) 2026-05-29 Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13) 2026-06-18 Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13) 2026-08-14 Early Redemption of Convertible Bonds (Incl. Overseas CBs) Prior to Maturity (Series 13)

Filed2026-08-31, Early redemption of convertible bonds (incl. overseas CBs)
SourceDART rcept 20260831900610 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-08-31 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).